| Year |
Citation |
Score |
| 2018 |
Farhana L, Antaki F, Murshed F, Mahmud H, Judd SL, Nangia-Makker P, Levi E, Yu Y, Majumdar AP. Gut microbiome profiling and colorectal cancer in African Americans and Caucasian Americans. World Journal of Gastrointestinal Pathophysiology. 9: 47-58. PMID 30283710 DOI: 10.4291/Wjgp.V9.I2.47 |
0.472 |
|
| 2017 |
Kanaan Z, Farhana L, Sarkar S, Antaki F, Judd S, Yu Y, Nangia-Makker P, Majumdar AP. Alterations in Gut Microbiome could Partly be Responsible for Racial Disparity in Colorectal Cancer Gastroenterology. 152: S420. DOI: 10.1016/S0016-5085(17)31630-X |
0.48 |
|
| 2017 |
Kanaan Z, Farhana L, Sarkar S, Antaki F, Judd S, Yu Y, Nangia-Makker P, Majumdar AP. Long Non-Coding RNAs: Potential Predictors of Racial Disparity in Colorectal Cancer Gastroenterology. 152: S419. DOI: 10.1016/S0016-5085(17)31629-3 |
0.374 |
|
| 2016 |
Farhana L, Nangia-Makker P, Arbit E, Shango K, Sarkar S, Mahmud H, Hadden T, Yu Y, Majumdar AP. Bile acid: a potential inducer of colon cancer stem cells. Stem Cell Research & Therapy. 7: 181. PMID 27908290 DOI: 10.1186/s13287-016-0439-4 |
0.424 |
|
| 2016 |
Goyal S, Nangia-Makker P, Farhana L, Yu Y, Majumdar AP. Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells. World Journal of Stem Cells. 8: 279-87. PMID 27679684 DOI: 10.4252/Wjsc.V8.I9.279 |
0.552 |
|
| 2016 |
Yang L, Levi E, Du J, Zhou H, Miller R, Majumdar AP. Associations between markers of colorectal cancer stem cells, mutation, miRNA and the clinical features of ulcerative colitis. Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland. PMID 27153478 DOI: 10.1111/codi.13371 |
0.348 |
|
| 2016 |
Farhana L, Antaki F, Anees MR, Nangia-Makker P, Judd S, Hadden T, Levi E, Murshed F, Yu Y, Van Buren E, Ahmed K, Dyson G, Majumdar AP. Role of cancer stem cells in racial disparity in colorectal cancer. Cancer Medicine. PMID 26990997 DOI: 10.1002/cam4.690 |
0.353 |
|
| 2016 |
Yang L, Levi E, Du J, Zhou H, Miller R, Majumdar AP. Associations between Markers of Colorectal Cancer Stem Cells, Mutations, Mirna, and Clinical Characteristics of Ulcerative Colitis Translational Medicine. 6: 1-7. DOI: 10.4172/2161-1025.1000168 |
0.396 |
|
| 2016 |
Goyal S, Farhana L, Antaki F, Judd S, Nangia-Makker P, Hadden T, Yu Y, Levi E, Majumdar A. Colorectal Cancer and Racial Disparity: Gut Microbiome as a Potential Regulator: 138 The American Journal of Gastroenterology. 111. DOI: 10.14309/00000434-201610001-00138 |
0.497 |
|
| 2015 |
Nangia-Makker P, Yu Y, Majumdar AP. Role of cancer stem cells in age-related rise in colorectal cancer. World Journal of Gastrointestinal Pathophysiology. 6: 86-89. PMID 26600965 DOI: 10.4291/Wjgp.V6.I4.86 |
0.545 |
|
| 2015 |
Yu Y, Nangia-Makker P, Farhana L, G Rajendra S, Levi E, Majumdar AP. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells. Molecular Cancer. 14: 98. PMID 25928322 DOI: 10.1186/s12943-015-0372-7 |
0.356 |
|
| 2015 |
Sharon C, Baranwal S, Patel NJ, Rodriguez-Agudo D, Pandak WM, Majumdar AP, Krystal G, Patel BB. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo. Oncotarget. 6: 15332-47. PMID 25895029 |
0.421 |
|
| 2015 |
Majumdar A, Nangia-Makker P, Yu Y. A Gradual Rise in Cancer Stem Cells in the Crypt-Villous Axis of the Colon During Aging The Faseb Journal. 29. DOI: 10.4172/1747-0862.S1.007 |
0.474 |
|
| 2015 |
Yu Y, Nangia-Makker P, Majumdar AP. 163 Gradual Rise in Cancer Stem Cells in the Crypt-Villous Axis of the Colon During Aging Gastroenterology. 148: S-44. DOI: 10.1016/S0016-5085(15)30152-9 |
0.532 |
|
| 2015 |
Farhana L, Antaki F, Judd S, Miller L, Anees MR, Levi E, Nangia-Makker P, Ahmed K, Yu Y, Majumdar AP. 161 Racial Disparities in Colorectal Cancer: Responsiveness to Bile Acids Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)30150-5 |
0.443 |
|
| 2014 |
Vasudevan A, Yu Y, Banerjee S, Woods J, Farhana L, Rajendra SG, Patel A, Dyson G, Levi E, Maddipati KR, Majumdar AP, Nangia-Makker P. Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer. Cancer Prevention Research (Philadelphia, Pa.). 7: 1138-48. PMID 25193342 DOI: 10.1158/1940-6207.CAPR-14-0177 |
0.527 |
|
| 2014 |
Levi E, Sochacki P, Khoury N, Patel BB, Majumdar AP. Cancer stem cells in Helicobacter pylori infection and aging: Implications for gastric carcinogenesis. World Journal of Gastrointestinal Pathophysiology. 5: 366-72. PMID 25133037 DOI: 10.4291/Wjgp.V5.I3.366 |
0.449 |
|
| 2014 |
Nangia-Makker P, Yu Y, Vasudevan A, Farhana L, Rajendra SG, Levi E, Majumdar AP. Metformin: a potential therapeutic agent for recurrent colon cancer. Plos One. 9: e84369. PMID 24465408 DOI: 10.1371/journal.pone.0084369 |
0.531 |
|
| 2014 |
Antaki F, Farhana L, Miller LA, Anees MR, Yu Y, Nangia-Makker P, Levi E, Majumdar AP. Mo1152 The Role of Cancer Stem Cells in the Increased Risk of Colorectal Cancer in African-Americans Gastroenterology. 146: S-571. DOI: 10.1016/S0016-5085(14)62068-0 |
0.399 |
|
| 2014 |
Yu Y, Nagia-Makker P, Rajendra S, Levi E, Majumdar AP. 397 MicoRNA's in Regulation of Colon Cancer Stem Cells Gastroenterology. 146: S-85. DOI: 10.1016/S0016-5085(14)60305-X |
0.306 |
|
| 2013 |
Yang L, Levi E, Zhu S, Du J, Majumdar AP. Cancer stem cells biomarkers in gastric carcinogenesis. Journal of Gastrointestinal Cancer. 44: 428-35. PMID 23949555 DOI: 10.1007/s12029-013-9534-2 |
0.374 |
|
| 2013 |
Roy S, Yu Y, Padhye SB, Sarkar FH, Majumdar AP. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. Plos One. 8: e68543. PMID 23894315 DOI: 10.1371/Journal.Pone.0068543 |
0.451 |
|
| 2013 |
Yu Y, Sarkar FH, Majumdar AP. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens. Translational Oncology. 6: 180-6. PMID 23544170 DOI: 10.1593/Tlo.12397 |
0.493 |
|
| 2013 |
Epifano F, Genovese S, Miller R, Majumdar AP. Auraptene and its effects on the re-emergence of colon cancer stem cells. Phytotherapy Research : Ptr. 27: 784-6. PMID 22761031 DOI: 10.1002/ptr.4773 |
0.497 |
|
| 2013 |
Yu Y, Sarkar F, Majumdar AP. Tu1593 Downregulation of miR-21 Induces Differentiation of Chemo-Resistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)62962-5 |
0.455 |
|
| 2012 |
Roy S, Majumdar AP. Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes. Journal of Stem Cell Research & Therapy. PMID 23565347 DOI: 10.4172/2157-7633.S7-006 |
0.467 |
|
| 2012 |
Roy S, Majumdar AP. Signaling in colon cancer stem cells. Journal of Molecular Signaling. 7: 11. PMID 22866952 DOI: 10.1186/1750-2187-7-11 |
0.474 |
|
| 2012 |
Leavell BJ, Van Buren E, Antaki F, Axelrod BN, Rambus MA, Majumdar AP. Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups. Digestive Diseases and Sciences. 57: 2334-9. PMID 22562538 DOI: 10.1007/S10620-012-2195-3 |
0.396 |
|
| 2012 |
Kanwar SS, Poolla A, Majumdar AP. Regulation of colon cancer recurrence and development of therapeutic strategies. World Journal of Gastrointestinal Pathophysiology. 3: 1-9. PMID 22368781 DOI: 10.4291/Wjgp.V3.I1.1 |
0.559 |
|
| 2012 |
Nautiyal J, Du J, Yu Y, Kanwar SS, Levi E, Majumdar AP. EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine. American Journal of Physiology. Gastrointestinal and Liver Physiology. 302: G655-63. PMID 22281474 DOI: 10.1152/Ajpgi.00323.2011 |
0.778 |
|
| 2012 |
Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, Majumdar AP. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 33: 68-76. PMID 22072622 DOI: 10.1093/Carcin/Bgr246 |
0.728 |
|
| 2012 |
Levi E, Du J, Leavell BJ, Yang L, Sethi S, Antaki F, Majumdar AP. Sa1767 Cancer Stem Cells in the Age-Related Progression of Colorectal Cancer: Role of EGFR Gastroenterology. 142: S-321. DOI: 10.1016/S0016-5085(12)61204-9 |
0.567 |
|
| 2012 |
Leavell B, Du J, Antaki F, Levi E, Majumdar AP. Interaction of cancer stem-like cells and epidermal growth factor receptor (EGFR) in the pathogenetic evolution of the age-related rise in colorectal carcinomas Regulatory Peptides. 177: S25. DOI: 10.1016/J.Regpep.2012.05.050 |
0.433 |
|
| 2011 |
Levi E, Majumdar AP. Cancer stem cells in ulcerative colitis. Onkologie. 34: 660-2. PMID 22156444 DOI: 10.1159/000334812 |
0.442 |
|
| 2011 |
Nautiyal J, Kanwar SS, Yu Y, Majumdar AP. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. Journal of Molecular Signaling. 6: 7. PMID 21774804 DOI: 10.1186/1750-2187-6-7 |
0.786 |
|
| 2011 |
Oh PS, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G347-55. PMID 21596996 DOI: 10.1152/Ajpgi.00403.2010 |
0.79 |
|
| 2011 |
Sanders MA, Majumdar AP. Colon cancer stem cells: implications in carcinogenesis. Frontiers in Bioscience (Landmark Edition). 16: 1651-62. PMID 21196254 DOI: 10.2741/3811 |
0.501 |
|
| 2011 |
Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, Majumdar AP. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharmaceutical Research. 28: 827-38. PMID 21161336 DOI: 10.1007/S11095-010-0336-Y |
0.796 |
|
| 2011 |
Nautiyal J, Banerjee S, Kanwar SS, Yu Y, Patel BB, Sarkar FH, Majumdar AP. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. International Journal of Cancer. 128: 951-61. PMID 20473900 DOI: 10.1002/Ijc.25410 |
0.806 |
|
| 2011 |
Nautiyal J, Yu Y, Kanwar SS, Patel BB, Majumdar AP. Abstract 3503: Targeting chemo-resistant colon cancer cells by the combination of dasatinib and curcumin: A novel therapeutic strategy Cancer Research. 71: 3503-3503. DOI: 10.1158/1538-7445.Am2011-3503 |
0.804 |
|
| 2011 |
Levi E, Malecka-Panas E, Mokrowiecka A, Du J, Sochacki P, Khoury N, Patel BB, Majumdar AP. Induction of Cancer Stem Cells During Progression From Barrett's Esophagus to Esoghageal Adenocarcinoma Gastroenterology. 140. DOI: 10.1016/S0016-5085(11)63446-X |
0.522 |
|
| 2011 |
Nautiyal J, Kanwar SS, Leavell BJ, Du J, Patel BB, Levi E, Majumdar AP. Cancer Stem Cells: Implications for Age-Related Rise in Colorectal Carcinogenesis Gastroenterology. 140: S-830. DOI: 10.1016/S0016-5085(11)63442-2 |
0.777 |
|
| 2011 |
Patel BB, Yu Y, Du J, Levi E, Majumdar AP. IGF-1R Modulates Colon Cancer Stem Cell Properties by Regulating Novel Tumor Suppressor MicroRNAs Gastroenterology. 140: S-121. DOI: 10.1016/S0016-5085(11)60492-7 |
0.463 |
|
| 2010 |
Patel BB, Yu Y, Du J, Majumdar AP. IGF-1R regulation of colon cancer stem cells. Regulatory Peptides. 164: 47. PMID 26009454 DOI: 10.1016/j.regpep.2010.07.124 |
0.392 |
|
| 2010 |
Patel VB, Misra S, Patel BB, Majumdar AP. Colorectal cancer: chemopreventive role of curcumin and resveratrol. Nutrition and Cancer. 62: 958-67. PMID 20924971 DOI: 10.1080/01635581.2010.510259 |
0.434 |
|
| 2010 |
Markle B, May EJ, Majumdar AP. Do nutraceutics play a role in the prevention and treatment of colorectal cancer? Cancer Metastasis Reviews. 29: 395-404. PMID 20717706 DOI: 10.1007/s10555-010-9234-3 |
0.366 |
|
| 2010 |
Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Molecular Cancer. 9: 212. PMID 20691072 DOI: 10.1186/1476-4598-9-212 |
0.767 |
|
| 2010 |
Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Du J, Patel BB, Sarkar FH, Rishi AK, Mohammad RM, Majumdar AP. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells. Molecular Cancer Therapeutics. 9: 1503-14. PMID 20515951 DOI: 10.1158/1535-7163.Mct-10-0019 |
0.788 |
|
| 2010 |
Nautiyal J, Kanwar SS, Majumdar AP. EGFR(s) in aging and carcinogenesis of the gastrointestinal tract. Current Protein & Peptide Science. 11: 436-50. PMID 20491625 DOI: 10.2174/138920310791824110 |
0.758 |
|
| 2010 |
Patel BB, Gupta D, Elliott AA, Sengupta V, Yu Y, Majumdar AP. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Research. 30: 319-25. PMID 20332435 |
0.45 |
|
| 2010 |
Kato I, Land S, Majumdar AP, Barnholtz-Sloan J, Severson RK. Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer. Cancer Epidemiology. 34: 291-7. PMID 20308031 DOI: 10.1016/J.Canep.2010.02.010 |
0.361 |
|
| 2010 |
Yuan L, Yu Y, Sanders MA, Majumdar AP, Basson MD. Schlafen 3 induction by cyclic strain regulates intestinal epithelial differentiation. American Journal of Physiology. Gastrointestinal and Liver Physiology. 298: G994-G1003. PMID 20299602 DOI: 10.1016/J.Jss.2009.11.057 |
0.318 |
|
| 2010 |
Kanwar SS, Nautiyal J, Majumdar AP. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new? Current Drug Targets. 11: 682-98. PMID 20298154 DOI: 10.2174/138945010791170851 |
0.765 |
|
| 2010 |
Kato I, Nechvatal JM, Dzinic S, Basson MD, Majumdar AP, Ram JL. Smoking and other personal characteristics as potential predictors for fecal bacteria populations in humans. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 16: CR1-7. PMID 20037488 |
0.304 |
|
| 2010 |
Kato I, Majumdar AP, Land SJ, Barnholtz-Sloan JS, Severson RK. Dietary fatty acids, luminal modifiers, and risk of colorectal cancer. International Journal of Cancer. 127: 942-51. PMID 19998336 DOI: 10.1002/Ijc.25103 |
0.336 |
|
| 2010 |
Patel B, Yu Y, Majumdar AP. IGF-1R: A therapeutic target for colon cancer stem-like cells. Journal of Clinical Oncology. 28: e14131-e14131. DOI: 10.1200/JCO.2010.28.15_SUPPL.E14131 |
0.396 |
|
| 2010 |
Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Sarkar FH, Rishi AK, Mohammad R, Patel BB, Majumdar A. Abstract 5406: ErbB inhibitory protein [EBIP], a modified ectodomain of EGFR, synergizes with dasatinib to inhibit growth of breast cancer cells Cancer Research. 70: 5406-5406. DOI: 10.1158/1538-7445.Am10-5406 |
0.801 |
|
| 2010 |
Levi E, Du J, Sochacki P, Khoury N, Patel BB, Majumdar AP. T1749 Helicobacter pylori Infection and Aging are Associated With an Increase in the Cancer-Stem Cell Population in Gastric Mucosa Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62627-3 |
0.399 |
|
| 2010 |
Yu Y, Patel BB, Majumdar AP. T1744 Curcumin Augments PDCD4 by Downregulating MicroRNA-21 in Colon Cancer Cells Gastroenterology. 138: S-569. DOI: 10.1016/S0016-5085(10)62622-4 |
0.51 |
|
| 2010 |
Nautiyal J, Banerjee S, Kanwar SS, Sarkar F, Majumdar AP. T1170 Curcumin Synergizes With C-SRC Inhibitor Dasatinib in Inhibiting Colon Cancer Gastroenterology. 138: S-503-S-504. DOI: 10.1016/S0016-5085(10)62325-6 |
0.763 |
|
| 2010 |
Patel BB, Yu Y, Majumdar AP. 568 IGF-1R: A Therapeutic Target for Colon Cancer Stem-Like Cells Gastroenterology. 138: S-80. DOI: 10.1016/S0016-5085(10)60363-0 |
0.493 |
|
| 2009 |
Kato I, Badsha KZ, Land S, Nechvatal JM, Matherly LH, Tarca AL, Majumdar AP, Basson MD, Ram JL. DNA/RNA markers for colorectal cancer risk in preserved stool specimens: a pilot study. Tumori. 95: 753-61. PMID 20210241 DOI: 10.1700/467.5517 |
0.355 |
|
| 2009 |
Patel BB, Majumdar AP. Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutrition and Cancer. 61: 842-6. PMID 20155625 DOI: 10.1080/01635580903285106 |
0.453 |
|
| 2009 |
Ahmad A, Banerjee S, Wang Z, Kong D, Majumdar AP, Sarkar FH. Aging and inflammation: etiological culprits of cancer. Current Aging Science. 2: 174-86. PMID 19997527 DOI: 10.2174/1874609810902030174 |
0.334 |
|
| 2009 |
Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Translational Oncology. 2: 321-8. PMID 19956394 DOI: 10.1593/Tlo.09193 |
0.8 |
|
| 2009 |
Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E, Sarkar FH. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutrition and Cancer. 61: 544-53. PMID 19838927 DOI: 10.1080/01635580902752262 |
0.805 |
|
| 2009 |
Levi E, Misra S, Du J, Patel BB, Majumdar AP. Combination of aging and dimethylhydrazine treatment causes an increase in cancer-stem cell population of rat colonic crypts. Biochemical and Biophysical Research Communications. 385: 430-3. PMID 19465005 DOI: 10.1016/j.bbrc.2009.05.080 |
0.49 |
|
| 2009 |
Nautiyal J, Majumder P, Patel BB, Lee FY, Majumdar AP. Src inhibitor dasatinib inhibits growth of breast cancer cells by modulating EGFR signaling. Cancer Letters. 283: 143-51. PMID 19398150 DOI: 10.1016/J.Canlet.2009.03.035 |
0.783 |
|
| 2009 |
Giri B, Gomes A, Sengupta R, Banerjee S, Nautiyal J, Sarkar FH, Majumdar AP. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Anticancer Research. 29: 395-401. PMID 19331178 |
0.762 |
|
| 2009 |
Patel BB, Yu Y, Du J, Levi E, Phillip PA, Majumdar AP. Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer. Biochemical and Biophysical Research Communications. 378: 344-7. PMID 19010307 DOI: 10.1016/j.bbrc.2008.10.179 |
0.484 |
|
| 2009 |
Nautiyal J, Yu Y, Patel B, Majumdar A. Targeting EGFRs and Src signaling with a modified ectodomain of human EGFR (EBIP) and dasatinib in breast cancer. Cancer Research. 69: 3069. DOI: 10.1158/0008-5472.Sabcs-3069 |
0.798 |
|
| 2008 |
Milacic V, Banerjee S, Landis-Piwowar KR, Sarkar FH, Majumdar AP, Dou QP. Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Research. 68: 7283-92. PMID 18794115 DOI: 10.1158/0008-5472.Can-07-6246 |
0.442 |
|
| 2008 |
Patel BB, Sengupta R, Qazi S, Vachhani H, Yu Y, Rishi AK, Majumdar AP. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. International Journal of Cancer. Journal International Du Cancer. 122: 267-73. PMID 17918158 DOI: 10.1002/ijc.23097 |
0.481 |
|
| 2007 |
Majumdar AP, Du J, Yu Y, Xu H, Levi E, Patel BB, Rishi AK. Cell cycle and apoptosis regulatory protein-1: a novel regulator of apoptosis in the colonic mucosa during aging. American Journal of Physiology. Gastrointestinal and Liver Physiology. 293: G1215-22. PMID 17932228 DOI: 10.1152/ajpgi.00324.2007 |
0.336 |
|
| 2007 |
Schmelz EM, Xu H, Sengupta R, Du J, Banerjee S, Sarkar FH, Rishi AK, Majumdar AP. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein. Cancer Research. 67: 5389-96. PMID 17545620 DOI: 10.1158/0008-5472.Can-07-0536 |
0.425 |
|
| 2007 |
Zhang L, Levi E, Majumder P, Yu Y, Aboukameel A, Du J, Xu H, Mohammad R, Hatfield JS, Wali A, Adsay V, Majumdar AP, Rishi AK. Transactivator of transcription-tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo. Molecular Cancer Therapeutics. 6: 1661-72. PMID 17513614 DOI: 10.1158/1535-7163.Mct-06-0653 |
0.413 |
|
| 2007 |
Schmelz EM, Xu H, Du J, Sarkar FH, Rishi A, Majumdar AP. TREATMENT OF EARLY AND INTERMEDIATE STAGES OF COLORECTAL CANCER WITH EGF‐RECEPTOR RELATED PROTEIN (ERRP). The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A31 |
0.421 |
|
| 2006 |
Nautiyal J, Rishi AK, Majumdar AP. Emerging therapies in gastrointestinal cancers. World Journal of Gastroenterology. 12: 7440-50. PMID 17167831 DOI: 10.3748/Wjg.V12.I46.7440 |
0.774 |
|
| 2006 |
Reddy S, Rishi AK, Xu H, Levi E, Sarkar FH, Majumdar AP. Mechanisms of curcumin- and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells. Nutrition and Cancer. 55: 185-94. PMID 17044774 DOI: 10.1207/S15327914Nc5502_10 |
0.503 |
|
| 2006 |
Wang Z, Sengupta R, Banerjee S, Li Y, Zhang Y, Rahman KM, Aboukameel A, Mohammad R, Majumdar AP, Abbruzzese JL, Sarkar FH. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. Cancer Research. 66: 7653-60. PMID 16885366 DOI: 10.1158/0008-5472.Can-06-1019 |
0.49 |
|
| 2006 |
Rishi AK, Parikh R, Wali A, Durko L, Zhang L, Yu Y, Majumdar AP. EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro. Anticancer Research. 26: 1029-37. PMID 16619503 |
0.473 |
|
| 2006 |
Rishi AK, Zhang L, Yu Y, Jiang Y, Nautiyal J, Wali A, Fontana JA, Levi E, Majumdar AP. Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. The Journal of Biological Chemistry. 281: 13188-98. PMID 16543231 DOI: 10.1074/Jbc.M512279200 |
0.715 |
|
| 2006 |
Zhang Y, Banerjee S, Wang Z, Xu H, Zhang L, Mohammad R, Aboukameel A, Adsay NV, Che M, Abbruzzese JL, Majumdar AP, Sarkar FH. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Research. 66: 1025-32. PMID 16424038 DOI: 10.1158/0008-5472.Can-05-2968 |
0.484 |
|
| 2005 |
Majumdar AP. Therapeutic potential of EGFR-related protein, a universal EGFR family antagonist Future Oncology. 1: 235-245. PMID 16555995 DOI: 10.1517/14796694.1.2.235 |
0.387 |
|
| 2005 |
Zhang Y, Banerjee S, Wang ZW, Marciniak DJ, Majumdar AP, Sarkar FH. Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells. Cancer Research. 65: 3877-82. PMID 15867387 DOI: 10.1158/0008-5472.Can-04-3654 |
0.472 |
|
| 2005 |
Xu H, Yu Y, Marciniak D, Rishi AK, Sarkar FH, Kucuk O, Majumdar AP. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells. Molecular Cancer Therapeutics. 4: 435-42. PMID 15767552 DOI: 10.1158/1535-7163.Mct-04-0280 |
0.502 |
|
| 2005 |
Moon WS, Tarnawski AS, Chai J, Yang JT, Majumdar AP. Reduced expression of epidermal growth factor receptor related protein in gastric cancer. Gut. 54: 201-6. PMID 15647181 DOI: 10.1136/GUT.2003.027078 |
0.386 |
|
| 2004 |
Marciniak DJ, Rishi AK, Sarkar FH, Majumdar AP. Epidermal growth factor receptor-related peptide inhibits growth of PC-3 prostate cancer cells. Molecular Cancer Therapeutics. 3: 1615-21. PMID 15634655 |
0.424 |
|
| 2004 |
Schmelz EM, Levi E, Du J, Xu H, Majumdar AP. Age-related loss of EGF-receptor related protein (ERRP) in the aging colon is a potential risk factor for colon cancer. Mechanisms of Ageing and Development. 125: 917-22. PMID 15563939 DOI: 10.1016/j.mad.2004.03.010 |
0.314 |
|
| 2004 |
Levi E, Mohammad R, Kodali U, Marciniak D, Reddy S, Aboukameel A, Sarkar FH, Kucuk O, Rishi AK, Majumdar AP. EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo. Anticancer Research. 24: 2885-91. PMID 15517892 |
0.429 |
|
| 2004 |
Majumdar AP, Kodali U, Jaszewski R. Chemopreventive role of folic acid in colorectal cancer. Frontiers in Bioscience : a Journal and Virtual Library. 9: 2725-32. PMID 15353309 |
0.439 |
|
| 2004 |
Moon WS, Chang KJ, Majumdar AP, Tarnawski AS. Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma: implications for cancer growth. Digestion. 69: 219-24. PMID 15205570 DOI: 10.1159/000079151 |
0.324 |
|
| 2004 |
Nagothu KK, Rishi AK, Jaszewski R, Kucuk O, Majumdar AP. Folic acid-mediated inhibition of serum-induced activation of EGFR promoter in colon cancer cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 287: G541-6. PMID 15075253 DOI: 10.1152/ajpgi.00365.2003 |
0.436 |
|
| 2004 |
Zhang Y, Banerjee S, Majumdar A, Sarkar F. INHIBITION OF PANCREATIC CANCER CELL GROWTH BY AN E PIDERMAL GROWTH FACTOR R ECEPTOR-R ELATED P ROTEIN (ERRP). Pancreas. 29: 365. DOI: 10.1097/00006676-200411000-00148 |
0.41 |
|
| 2003 |
Rishi AK, Zhang L, Boyanapalli M, Wali A, Mohammad RM, Yu Y, Fontana JA, Hatfield JS, Dawson MI, Majumdar AP, Reichert U. Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437. The Journal of Biological Chemistry. 278: 33422-35. PMID 12816952 DOI: 10.1074/Jbc.M303173200 |
0.317 |
|
| 2003 |
Marciniak DJ, Moragoda L, Mohammad RM, Yu Y, Nagothu KK, Aboukameel A, Sarkar FH, Adsay VN, Rishi AK, Majumdar AP. Epidermal growth factor receptor-related protein: a potential therapeutic agent for colorectal cancer. Gastroenterology. 124: 1337-47. PMID 12730874 DOI: 10.1016/S0016-5085(03)00264-6 |
0.397 |
|
| 2003 |
Durko L, Sanders MA, Majumdar AP, Basson MD. Role of EGFR related protein (ERRP) in gut epithelial motility and differentiation Gastroenterology. 124: A596. DOI: 10.1016/S0016-5085(03)83022-6 |
0.34 |
|
| 2001 |
Xiao ZQ, Moragoda L, Jaszewski R, Hatfield JA, Fligiel SE, Majumdar AP. Aging is associated with increased proliferation and decreased apoptosis in the colonic mucosa. Mechanisms of Ageing and Development. 122: 1849-64. PMID 11557285 DOI: 10.1016/S0016-5085(00)84306-1 |
0.426 |
|
| 2001 |
Moragoda L, Jaszewski R, Majumdar AP. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells Gastroenterology. 120: A666. DOI: 10.1016/S0016-5085(08)83313-6 |
0.382 |
|
| 2000 |
Xiao Z, Majumdar AP. Induction of transcriptional activity of AP-1 and NF-kB in the gastric mucosa during aging Gastroenterology. 118: A544-A545. DOI: 10.1016/S0016-5085(00)84310-3 |
0.335 |
|
| 2000 |
Yu Y, Xiao Z, Rishi AK, Majumdar AP. Regulation of ERRP-induced inhibition of proliferation in HCT-116 colon cancer cell line Gastroenterology. 118: A539. DOI: 10.1016/S0016-5085(00)84285-7 |
0.518 |
|
| 1999 |
Jaszewski R, Ehrinpreis MN, Majumdar AP. Aging and cancer of the stomach and colon. Frontiers in Bioscience : a Journal and Virtual Library. 4: D322-8. PMID 10077539 DOI: 10.2741/JASZEWSK |
0.368 |
|
| Show low-probability matches. |